C07K 16/461
Igs containing ig-regions, -domains or -residues form different species
Official title: {Igs containing Ig-regions, -domains or -residues form different species}
C07K16/461 (Igs containing ig-regions, -domains or -residues form different species) appears on 721 US grants and 965 published applications in this corpus.
Search patents in C07K- Granted patents
- 721
- Published applications
- 965
- Assignees
- 355
- Inventors
- 1,124
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 13 | 0 |
| 1997 | 16 | 0 |
| 1998 | 23 | 0 |
| 1999 | 22 | 0 |
| 2000 | 12 | 0 |
| 2001 | 16 | 0 |
| 2002 | 9 | 9 |
| 2003 | 15 | 30 |
| 2004 | 8 | 31 |
| 2005 | 7 | 33 |
| 2006 | 11 | 30 |
| 2007 | 11 | 25 |
| 2008 | 11 | 18 |
| 2009 | 14 | 39 |
| 2010 | 21 | 31 |
| 2011 | 17 | 47 |
| 2012 | 32 | 38 |
| 2013 | 31 | 71 |
| 2014 | 30 | 70 |
| 2015 | 47 | 63 |
| 2016 | 47 | 52 |
| 2017 | 34 | 60 |
| 2018 | 32 | 44 |
| 2019 | 26 | 34 |
| 2020 | 42 | 52 |
| 2021 | 30 | 43 |
| 2022 | 30 | 45 |
| 2023 | 29 | 27 |
| 2024 | 31 | 40 |
| 2025 | 25 | 22 |
| 2026 | 13 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antibodies recognizing tau15 Sep 2026US 12,735,507 B2Prothena Biosciences Limited
- Humanized non-human animals with restricted immunoglobulin heavy chain loci14 Jul 2026US 12,677,812 B2Regeneron Pharmaceuticals, Inc.
- Engineered immunoglobulins with altered FcRn binding7 Jul 2026US 12,674,004 B2Universitetet I Oslo
- Methionine containing antibodies for conjugation of agents2 Jun 2026US 12,642,864 B2The Regents of the University of California
- Methods and compositions for reducing the immunogenicity of chimeric notch receptors5 May 2026US 12,617,825 B2Cell Design Labs, Inc.
- Treatment of sjogren's disease with nuclease fusion proteins3 Sep 2026US 2026/0258159 A1Resolve Therapeutics, LLC
- Methods and compositions for treating staphylococcal infections27 Aug 2026US 2026/0250425 A1The University of Chicago
- Bispecific binding agents for use in companion animals13 Aug 2026US 2026/0234262 A1Invetx, Inc.
- Novel anti-l1cam antibody4 Jun 2026US 2026/0152552 A1Curon Biopharmaceutical (Shanghai) Co., Limited
- Novel compositions and methods for treating ige-mediated disorders4 Jun 2026US 2026/0152574 A1Xencor, Inc.
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Recombinant altered antibodies and methods of making altered antibodies1,968US 5,225,539 AMedical Research Council · 1993